The impact of transdermal Testosterone Nanoemulsion on lipid profile in women with Hypoactive Sexual Desire: A double-blind randomized controlled study

universidade federal de sao paulo0 个研究点开始时间: 2021年11月3日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Women over 18 years old; maximum age 45 years; Decreased sexual desire; Present sexual activity, with at least one sexual event per month, with current partner; Be in good general health; Women over 40 should have a clinically acceptable mammogram within the last 2 years; Be on contraceptive method.

•Exclusion Criteria:Sexual dysfunction caused by another medical condition;Body mass index (BMI) below 18 kg / m2 or above 35 kg / m2; undiagnosed genital bleeding;Use of androgen therapy in the last 6 months (testosterone implant, testosterone transdermal cream, tibolone, oral testosterone or injectable testosterone); Antiandrogenic therapy for acne or hirsutism in the last 5 years; Hyperandrogenism Syndrome, such as Polycystic Ovary Syndrome; Moderate or severe acne, hirsutism, and androgenetic alopecia; Any serious clinical or psychiatric illness, active cancer, or treatment of malignancy within the last six months; Decompensated clinical disease; Any clinically significant skin abnormalities in the study medication application area; Consumption of more than three standard alcoholic drinks per day; pregnancy or lactation; Do not attend our center for follow-up study visits.

发起方